The perplexity of prescribing and switching of biologic drugs in rheumatoid arthritis: a UK regional audit of practice

BACKGROUND: Biologic drugs are expensive treatments used in rheumatoid arthritis (RA). Switching among them is common practice in patients who have had an inadequate response or intolerable adverse events. The National Institute of Health and Clinical Excellence (NICE) UK, which aims to curtail post...

Descripción completa

Detalles Bibliográficos
Autores principales: Blake, Tim, Rao, Vijay, Hashmi, Tahir, Erb, Nicola, O’Reilly, Sheila Catherine, Shaffu, Shireen, Obrenovic, Karen, Packham, Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164745/
https://www.ncbi.nlm.nih.gov/pubmed/25182696
http://dx.doi.org/10.1186/1471-2474-15-290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164745/
https://www.ncbi.nlm.nih.gov/pubmed/25182696
http://dx.doi.org/10.1186/1471-2474-15-290

Ejemplares similares